Zanubrutinib
BGB-3111-404
Approved small_molecule active
Quick answer
Zanubrutinib for Waldenström's Macroglobulinemia is a Approved program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Waldenström's Macroglobulinemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- active